Electra Therapeutics, Inc. (ETRA)

NASDAQ: ETRA · Real-Time Price · USD

11.82

-0.85 (-6.71%)

Sep 24, 2026, 4:00 PM EDT - Market closed

Electra Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	13.52	11.5	7.05
Research & Development	73.23	50.39	19.27
Operating Expenses	86.75	61.89	26.32
Operating Income	-86.75	-61.89	-26.32
Interest Expense	-1.11	-1.43	-
Interest & Investment Income	2.35	1.36	1.52
Currency Exchange Gain (Loss)	-0.02	-0.02	0.01
Pretax Income	-85.53	-61.98	-24.79
Net Income	-85.53	-61.98	-24.79
Net Income to Common	-95.2	-61.98	-24.79
Net Income Growth	-	-	-
Shares Outstanding (Basic)	0	0	0
Shares Outstanding (Diluted)	0	0	0
Shares Change	-	-	-
EPS (Basic)	-2163.66	-1408.52	-563.32
EPS (Diluted)	-2163.66	-1408.52	-563.32
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-75.32	-61.22	-26
Free Cash Flow Per Share	-1711.80	-1391.30	-590.98
EBITDA	-	-61.83	-
D&A For EBITDA	-	0.06	-
EBIT	-86.75	-61.89	-26.32

SEC Filings: 10-K · 10-Q